Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
January 28, 2022
DTRF Launches Radiomics Working Group To Improve Tumor Measurement
Read More about DTRF Launches Radiomics Working Group To Improve Tumor Measurement
January 24, 2022
Special Announcement: DTRF Co-Founder Marlene Portnoy Transitions To Board Of Directors
November 19, 2021
DTRF Receives Global Genes Champions Of Hope “Rare Champion In Advocacy (Foundation)” Award
October 26, 2021
Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
Read More about Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
October 4, 2021
Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
Read More about Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
September 30, 2021
Desmoid Tumor Awareness Month 2021 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2021 Comes To A Close
